@FiercePharma: ICYMI Friday: England to provide $GSK MenW vaccine to 3 million teens. FierceVaccines story | Follow @FiercePharma
@EricPFierce: GAO says FDA and DEA need to play better. The 2 can't even agree on what constitutes a drug shortage. FiercePharmaManufactuing article | Follow @EricPFierce
@CarlyHFierce: Endo Withdraws Proposal for Salix. Release | Follow @CarlyHFierce
> IMS Health Holdings ($IMS) gave its CEO a big pay boost for 2014, with a compensation package totaling $25.9 million, more than some of the biggest healthcare CEOs collect; the company went public last year, and CEO Ari Bousbib won a big stock award ahead of that offering. Report
> Johnson & Johnson's ($JNJ) anti-inflammatory drug Stelara won a thumbs up from U.K. cost-effectiveness watchdogs as a treatment for psoriatic arthritis. Report
> India's Lupin inked a deal to buy an additional 40% stake in the South African company Pharma Dynamics, gaining full control of the company in the process. Report
> The world's top 15 pharma companies saw their collective revenue drop to $546 billion from $555 billion last year, as the number of blockbuster meds dropped to 95 from 105. Report
Medical Device News
@FierceMedDev: Metabolon rides on last year's success with $5M in extended financing. FierceDiagnostics story | Follow @FierceMedDev
@VarunSaxena2: FDA expands indication of the only sublingual second-gen antipsychotic. FierceDrugDelivery article | Follow @VarunSaxena2
@EmilyWFierce: ICYMI: Metabolon rides on last year's success with $5M in extended financing. Story | Follow @EmilyWFierce
> St. Jude releases promising data on its heart failure system. Article
> Edwards and Medtronic turn up TAVR competition with positive study data. News
Biotech News
@FierceBiotech: Cidara Therapeutics makes a quick leap into the growing Q1 IPO queue. News | Follow @FierceBiotech
@JohnCFierce: We're up to about 600 responses to our bull vs. bubble survey. Today's your last shot at participating. Survey | Follow @JohnCFierce
@DamianFierce: Fun fact: The NEJM paper that got PCSK9 blockade rolling was published just nine years ago. Paper | Follow @DamianFierce
> Pulmatrix backs its way onto Wall Street with merger deal. Story
> Chiasma taps a new CEO as it rolls toward an FDA filing. Item
> R&D exec Tal Zaks leaps from flagging Sanofi to fast-growing Moderna. Report
Animal Health News
> Aratana Therapeutics reports lower Q4, full-year 2014 financials. News
> USDA to launch national equine study this spring. Item
> Hedge fund snaps up 5% of Valeant amid speculation of a Zoetis deal. More
> New FDA report finds banned antibiotics still showing up in dairy cow tests. Story
> USDA head calls halt to any new experiments at Nebraska facility. Article
Biotech IT News
> Y Combinator backs cancer drug combo testing service. Story
> Genomics England doles out $12M as sequencing yields early breakthroughs. More
> Google adds Tute database to burgeoning Genomics platform. Report
> UCB to host epilepsy digital tool hackathon. Item
> Apple turns 700M iPhone users into potential participants in massive virtual trials. Article
And Finally... An increase in fatty liver disease--and testing of new meds to treat it--have diagnostics makers looking for better methods of identifying the malady. Report